Borton ZM, Prasad G, Konstantopoulos G, et al. - Researchers interrogated a prospectively maintained local joint registry to yield a consecutive series of Discovery total elbow arthroplasty (TEA) conducted at a single non-design center. Survivorship of the implant was the primary endpoint. Clinical, radiographic, and patient-reported outcomes were included as secondary endpoints. Researchers distinguished 67 TEAs in 58 patients for inclusion at a mean 98.5(+/-20.4) months from surgery. They describe the longest-term and most complete single-center follow-up study of the Discovery TEA to date. Further long-term survival studies are needed to evaluate the performance of this implant compared to more established designs. Variations in implant survivorship due to hand dominance for the first time were also observed.